Institutional Ownership
Jasper Therapeutics Inc
CUSIP 471871111*W EXP 09/24/202JSPRWQ1 2026
13D / 13G Filings
0
Schedule 13D/13G on record
Beneficial Filers
0
Distinct reporting persons
Largest Stake
—
Max % of class reported
Institutional Holders
7
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
Schedule 13D (activist) & 13G (passive) 5%+ ownership filings
No 13D/13G filings on record yet
Schedule 13D/13G beneficial-ownership filings from 2020–present are ingested from SEC EDGAR. Coverage expands as the backfill and daily crawler run.
Top Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Boothbay Fund Management, LLC | 357.4K | $313.2K |
| 2 | Toronto Dominion Bank | 2.17M | $47.8K |
| 3 | Tenor Capital Management Co., L.P. | 250.0K | $5.5K |
| 4 | Walleye Capital LLC | 200.0K | $4.4K |
| 5 | Susquehanna International Group, LLP | 28.2K | $618 |
| 6 | Wolverine Asset Management LLC | 1.0K | $23 |
| 7 | Ifp Advisors, Inc | 50 | $1 |